UCL Hospitals
Biomedical Research Centre

A partnership between UCL and University College London Hospitals NHS Foundation Trust

NHS National Institute for Health Research

Home >> News >> BRC News
UCL awarded £10m to develop new dementia treatments 18 February 2015

UCL has been awarded £10m to fast-track the development of new treatments for Alzheimer’s disease and other dementias.

New biomarkers to spot pancreatic cancer early 6 February 2015

Pancreatic cancer could be diagnosed up to two years earlier by screening for two tumour markers found in blood, according to BRC-supported research.

Systemic amyloidosis drug one of first in adaptive licensing pilot 6 February 2015

A drug developed by UCL researchers and granted orphan drug designation is one of the first to take part in the newly launched adaptive licensing pilot project to speed up patients’ access to new medicines.

The drug is the first treatment aimed at directly removing amyloid deposits from the tissues of people with the rare and usually fatal disease, systemic amyloidosis.

Trial to identify undiscovered MS treatments 4 February 2015

Researchers have started a major trial to see if drugs normally prescribed for motor neurone disease, heart disease and depression could be some of the first therapies in the world to halt disability progression in people with multiple sclerosis (MS).

Bloomsbury Research Institute awarded £7.5 million 2 February 2015

UCL and the London School of Hygiene and Tropical Medicine have been awarded a grant of £7.5 million from the Higher Education Funding Council for England’s (HEFCE) Catalyst Fund to develop the Bloomsbury Research Institute, which aims to address the global challenge of infectious disease.

PPI workshops back by popular demand 28 January 2015

A series of patient and public involvement (PPI) workshops for clinical researchers is back by popular demand.